메뉴 건너뛰기




Volumn 29, Issue 1, 2015, Pages 77-90

Current topics in testosterone replacement of hypogonadal men

Author keywords

Cardiovascular disease; Diabetes mellitus; Late onset hypogonadiam; Metabolic syndrome; Osteoporosis; Primary hypogonadism; Secondary hypogonadism; Sexual function; Testosterone preparations; Testosterone substitution

Indexed keywords

HEMOGLOBIN; TESTOSTERONE; ANDROGEN; TESTOSTERONE UNDECANOATE;

EID: 84927928119     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2014.09.008     Document Type: Review
Times cited : (44)

References (106)
  • 2
    • 84927941535 scopus 로고    scopus 로고
    • Male hypogonadism and infertility
    • In: Wass AH, Stewart PM, Amiel SA, et al., editors. 2nd ed. Oxford: Oxford, University Press
    • Nieschlag E. Male hypogonadism and infertility. In: Wass AH, Stewart PM, Amiel SA, et al., editors. Oxford textbook of endocrinology and diabetes. 2nd ed. Oxford: Oxford, University Press; 2011. p. 1331-480.
    • (2011) Oxford Textbook of Endocrinology and Diabetes , pp. 1331-1480
    • Nieschlag, E.1
  • 3
    • 56749163628 scopus 로고    scopus 로고
    • Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations
    • Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008; 159: 507-14.
    • (2008) Eur J Endocrinol , vol.159 , pp. 507-514
    • Wang, C.1    Nieschlag, E.2    Swerdloff, R.3
  • 4
    • 77954409942 scopus 로고    scopus 로고
    • Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline
    • Bhasin S, Cunningham GR, Hayes FJ, et al., Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metabolism 2010; 6. 2536-259.
    • (2010) J Clin Endocrinol Metabolism , vol.6 , pp. 2536-2259
    • Bhasin, S.1    Cunningham, G.R.2    Hayes, F.J.3
  • 6
    • 84931311593 scopus 로고    scopus 로고
    • Review of guidelines on diagnosis and treatment of testosterone deficiency
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. University Press
    • Swerdloff RS, Wang CL. Review of guidelines on diagnosis and treatment of testosterone deficiency. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 408-20.
    • (2012) Cambridge: Cambridge , pp. 408-420
    • Swerdloff, R.S.1    Wang, C.L.2
  • 7
    • 84895832192 scopus 로고    scopus 로고
    • Testosterone lab testing and initiation in the United Kingdom and the United States, 2000-2011
    • Layton JB, Li D, Meier CR, et al. Testosterone lab testing and initiation in the United Kingdom and the United States, 2000-2011. J Clin Endocrinol Metabolism 2014; 99: 835-42.
    • (2014) J Clin Endocrinol Metabolism , vol.99 , pp. 835-842
    • Layton, J.B.1    Li, D.2    Meier, C.R.3
  • 8
    • 84883507909 scopus 로고    scopus 로고
    • A UK epidemic of testosterone prescribing, 2001-2010
    • Gan EH, Pattman S, Pearce S HS, et al. A UK epidemic of testosterone prescribing, 2001-2010. Clin Endocrinol 2013; 79: 564-70.
    • (2013) Clin Endocrinol , vol.79 , pp. 564-570
    • Gan, E.H.1    Pattman, S.2    Pearce S, H.S.3
  • 9
    • 0037793319 scopus 로고    scopus 로고
    • Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men
    • Diver MJ, Imtiaz KE, Ahmad AM, et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol 2003; 58: 710-7.
    • (2003) Clin Endocrinol , vol.58 , pp. 710-717
    • Diver, M.J.1    Imtiaz, K.E.2    Ahmad, A.M.3
  • 11
    • 33751533215 scopus 로고    scopus 로고
    • Association of specific symptoms and metabolic risks with serum testosterone in older men
    • Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metabolism 2006; 91: 4335-43.
    • (2006) J Clin Endocrinol Metabolism , vol.91 , pp. 4335-4343
    • Zitzmann, M.1    Faber, S.2    Nieschlag, E.3
  • 12
    • 4544264671 scopus 로고    scopus 로고
    • Testosterone replacement therapy: Current trends and future directions
    • Nieschlag E, Behre HM, Bouchard P, et al. Testosterone replacement therapy: Current trends and future directions. Hum Reprod Update 2004; 10: 409-19.
    • (2004) Hum Reprod Update , vol.10 , pp. 409-419
    • Nieschlag, E.1    Behre, H.M.2    Bouchard, P.3
  • 13
    • 77954414397 scopus 로고    scopus 로고
    • Identification of late-onset hypogonadism in middle-aged and elderly men
    • Wu FC, Tajar A, Beynon JM, et al., EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123-35.
    • (2010) N Engl J Med , vol.363 , pp. 123-135
    • Wu, F.C.1    Tajar, A.2    Beynon, J.M.3
  • 14
    • 84856939978 scopus 로고    scopus 로고
    • Diagnosing and treating testosterone deficiency in different parts of the world: Changes between 2006 and 2010
    • Gooren LJ, Behre HM. Diagnosing and treating testosterone deficiency in different parts of the world: Changes between 2006 and 2010. Aging Male 2012; 15: 22-7.
    • (2012) Aging Male , vol.15 , pp. 22-27
    • Gooren, L.J.1    Behre, H.M.2
  • 15
    • 80051560339 scopus 로고    scopus 로고
    • Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham heart study and applied to three geographically distinct cohorts
    • Bhasin S, Pencina M, Jasuja GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham heart study and applied to three geographically distinct cohorts. J Clin Endocrinol Metabolism 2011; 96: 2430-9.
    • (2011) J Clin Endocrinol Metabolism , vol.96 , pp. 2430-2439
    • Bhasin, S.1    Pencina, M.2    Jasuja, G.K.3
  • 16
    • 84867249434 scopus 로고    scopus 로고
    • Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: The healthy man study
    • Sartorius G, Spasevska S, Idan A, et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: The healthy man study. Clin Endocrinol 2012; 77: 755-63.
    • (2012) Clin Endocrinol , vol.77 , pp. 755-763
    • Sartorius, G.1    Spasevska, S.2    Idan, A.3
  • 17
    • 84861331756 scopus 로고    scopus 로고
    • Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men
    • Huhtaniemi IT, Tajar A, Lee DM, et al., EMAS Group. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol 2012; 166: 983-91.
    • (2012) Eur J Endocrinol , vol.166 , pp. 983-991
    • Huhtaniemi, I.T.1    Tajar, A.2    Lee, D.M.3
  • 18
    • 84876137627 scopus 로고    scopus 로고
    • Similar reference intervals for total testosterone in healthy young and elderly men: Results from the Odense androgen study
    • Frost M, Wraae K, Nielsen TL, et al. Similar reference intervals for total testosterone in healthy young and elderly men: Results from the Odense androgen study. Clin Endocrinol 2013; 78: 743-51.
    • (2013) Clin Endocrinol , vol.78 , pp. 743-751
    • Frost, M.1    Wraae, K.2    Nielsen, T.L.3
  • 19
    • 4444233038 scopus 로고    scopus 로고
    • A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men
    • Morris PD, Malkin CJ, Channer KS, et al. A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. Eur J Endocrinol 2004; 151: 241-9.
    • (2004) Eur J Endocrinol , vol.151 , pp. 241-249
    • Morris, P.D.1    Malkin, C.J.2    Channer, K.S.3
  • 20
    • 33846991956 scopus 로고    scopus 로고
    • Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement
    • Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement. J Clin Endocrinol Metabolism 2007; 92: 405-13.
    • (2007) J Clin Endocrinol Metabolism , vol.92 , pp. 405-413
    • Rosner, W.1    Auchus, R.J.2    Azziz, R.3
  • 21
    • 84927941225 scopus 로고    scopus 로고
    • Methodology for measuring testosterone, dihydrotestosterone and sex hormonebinding globulin in a clinical setting
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. 4th ed. Cambridge: Cambridge University Press
    • Simoni M, Fanelli F, Roli L, et al. Methodology for measuring testosterone, dihydrotestosterone and sex hormonebinding globulin in a clinical setting. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 60-86.
    • (2012) Testosterone: Action, Deficiency, Substitution , pp. 60-86
    • Simoni, M.1    Fanelli, F.2    Roli, L.3
  • 22
    • 84884858491 scopus 로고    scopus 로고
    • Testosterone and cardiometabolic risk in the general population-The impact of measurement method on risk associations: A comparative study between immunoassay and mass spectrometry
    • Haring R, Baumeister SE, Nauck M, et al. Testosterone and cardiometabolic risk in the general population-The impact of measurement method on risk associations: A comparative study between immunoassay and mass spectrometry. Eur J Endocrinol 2013; 169: 463-70.
    • (2013) Eur J Endocrinol , vol.169 , pp. 463-470
    • Haring, R.1    Baumeister, S.E.2    Nauck, M.3
  • 23
    • 84885222498 scopus 로고    scopus 로고
    • Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism
    • Handelsman DJ, Wartofsky L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metabolism 2013; 98: 3971-3.
    • (2013) J Clin Endocrinol Metabolism , vol.98 , pp. 3971-3973
    • Handelsman, D.J.1    Wartofsky, L.2
  • 24
    • 84896757113 scopus 로고    scopus 로고
    • Testosterone deficiency: A historical perspective [Invited review]
    • Nieschlag E, Nieschlag S. Testosterone deficiency: A historical perspective [Invited review] Asian J Androl 2014; 16: 161-8.
    • (2014) Asian J Androl , vol.16 , pp. 161-168
    • Nieschlag, E.1    Nieschlag, S.2
  • 25
    • 0004171841 scopus 로고
    • Geneva: WHO Special Programme of Research, Development and Research Training in Human Reproduction
    • Nieschlag E, Wang CH, Handelsman DJ, et al., editors. Guidelines for the use of androgens. Geneva: WHO Special Programme of Research, Development and Research Training in Human Reproduction; 1992.
    • (1992) Guidelines for the Use of Androgens
    • Nieschlag, E.1    Wang, C.H.2    Handelsman, D.J.3
  • 26
    • 84883699325 scopus 로고    scopus 로고
    • Gonadal steroids and body composition, strength, and sexual function in men
    • Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013; 369: 1011-22.
    • (2013) N Engl J Med , vol.369 , pp. 1011-1022
    • Finkelstein, J.S.1    Lee, H.2    Burnett-Bowie, S.A.3
  • 27
    • 84908503845 scopus 로고    scopus 로고
    • Male sexual function can be maintained without aromatization: Randomized placebo-controlled trial of dihydrotestosterone (DHT) in healthy, older men for 24 months
    • Sartorius GA, Ly LP, Handelsman DJ. Male sexual function can be maintained without aromatization: Randomized placebo-controlled trial of dihydrotestosterone (DHT) in healthy, older men for 24 months. J Sex Med 2014; 11: 2562-70.
    • (2014) J Sex Med , vol.11 , pp. 2562-2570
    • Sartorius, G.A.1    Ly, L.P.2    Handelsman, D.J.3
  • 28
    • 84896785795 scopus 로고    scopus 로고
    • The state-of-The-art in the development of selective androgen receptor modulators
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. 4th ed. Cambridge: Cambridge University Press
    • Jasuja R, Zacharov MN, Bhasin S. The state-of-The-art in the development of selective androgen receptor modulators. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 459-69.
    • (2012) Testosterone: Action, Deficiency, Substitution , pp. 459-469
    • Jasuja, R.1    Zacharov, M.N.2    Bhasin, S.3
  • 29
    • 84887872737 scopus 로고    scopus 로고
    • Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer
    • Dalton JT, Taylor RP, Mohler ML, et al. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer. Curr Opin Support Palliat Care 2013; 7: 345-51.
    • (2013) Curr Opin Support Palliat Care , vol.7 , pp. 345-351
    • Dalton, J.T.1    Taylor, R.P.2    Mohler, M.L.3
  • 30
    • 84866443683 scopus 로고    scopus 로고
    • Testosterone preparations for clinical use in males
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. 4th ed. Cambridge: Cambridge University Press
    • Behre HM, Nieschlag E. Testosterone preparations for clinical use in males. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 309-35.
    • (2012) Testosterone: Action, Deficiency, Substitution , pp. 309-335
    • Behre, H.M.1    Nieschlag, E.2
  • 31
    • 0033383771 scopus 로고    scopus 로고
    • Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men
    • Nieschlag E, Büchter D, von Eckardstein S, et al. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol 1999; 51: 757-63.
    • (1999) Clin Endocrinol , vol.51 , pp. 757-763
    • Nieschlag, E.1    Büchter, D.2    Von Eckardstein, S.3
  • 32
    • 35349019230 scopus 로고    scopus 로고
    • Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men
    • Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metabolism 2007; 92: 3844-53.
    • (2007) J Clin Endocrinol Metabolism , vol.92 , pp. 3844-3853
    • Zitzmann, M.1    Nieschlag, E.2
  • 33
    • 79953198275 scopus 로고    scopus 로고
    • Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals
    • Brabrand S, Fosså SD, Cvancarova M, et al. Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals. Br J Urol Int 2011; 107: 1080-7.
    • (2011) Br J Urol Int , vol.107 , pp. 1080-1087
    • Brabrand, S.1    Fosså, S.D.2    Cvancarova, M.3
  • 34
    • 85030396573 scopus 로고
    • Tolerability of intramuscular injections of testosterone ester in oil vehicle
    • Mackey MA, Conway AJ, Handelsman DJ. Tolerability of intramuscular injections of testosterone ester in oil vehicle. Hum Reprod 1995; 108. 62-865.
    • (1995) Hum Reprod , vol.108 , pp. 62-865
    • Mackey, M.A.1    Conway, A.J.2    Handelsman, D.J.3
  • 36
    • 77957834802 scopus 로고    scopus 로고
    • Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: An 84-week phase III clinical trial
    • Wang C, Harnett M, Dobs AS, et al. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: An 84-week phase III clinical trial. J Androl 2010; 31: 457-65.
    • (2010) J Androl , vol.31 , pp. 457-465
    • Wang, C.1    Harnett, M.2    Dobs, A.S.3
  • 37
    • 84874409333 scopus 로고    scopus 로고
    • Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets
    • Pastuszak AW, Mittakanti H, Liu JS, et al. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl 2012; 33: 927-37.
    • (2012) J Androl , vol.33 , pp. 927-937
    • Pastuszak, A.W.1    Mittakanti, H.2    Liu, J.S.3
  • 38
    • 0032721011 scopus 로고    scopus 로고
    • Extrusion of testosterone pellets: A randomized controlled clinical study
    • Kelleher S, Turner L, Howe C, et al. Extrusion of testosterone pellets: A randomized controlled clinical study. Clin Endocrinol 1999; 51: 469-71.
    • (1999) Clin Endocrinol , vol.51 , pp. 469-471
    • Kelleher, S.1    Turner, L.2    Howe, C.3
  • 39
    • 77953760547 scopus 로고    scopus 로고
    • Randomized cross-over clinical trial of injectable vs. Implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men
    • Fennell C, Sartorius G, Ly LP, et al. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men. Clin Endocrinol 2010; 73: 102-9.
    • (2010) Clin Endocrinol , vol.73 , pp. 102-109
    • Fennell, C.1    Sartorius, G.2    Ly, L.P.3
  • 40
    • 0016742354 scopus 로고
    • Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate
    • Nieschlag E, Mauss J, Coert A, et al. Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol (Copenh) 1975; 79: 366-74.
    • (1975) Acta Endocrinol (Copenh , vol.79 , pp. 366-374
    • Nieschlag, E.1    Mauss, J.2    Coert, A.3
  • 41
    • 0037370043 scopus 로고    scopus 로고
    • Important effect of food on the bioavailability of oral testosterone undecanoate
    • Bagchus WM, Hust R, Maris F, et al. Important effect of food on the bioavailability of oral testosterone undecanoate. Pharmacotherapy 2003; 23: 319-25.
    • (2003) Pharmacotherapy , vol.23 , pp. 319-325
    • Bagchus, W.M.1    Hust, R.2    Maris, F.3
  • 42
    • 0002629334 scopus 로고
    • Safety aspects of androgen therapy
    • In: Nieschlag E, Behre HM, editors. 1st ed. Heidelberg: Springer
    • Gooren LJG, Polderman KH. Safety aspects of androgen therapy. In: Nieschlag E, Behre HM, editors. Testosterone: Action, deficiency, substitution. 1st ed. Heidelberg: Springer; 1990. p. 182-203.
    • (1990) Testosterone: Action, Deficiency, Substitution , pp. 182-203
    • Gooren, L.J.G.1    Polderman, K.H.2
  • 43
    • 84874409467 scopus 로고    scopus 로고
    • Dietary fat modulates the testosterone pharmacokinetics of a new self-emulsifying formulation of oral testosterone undecanoate in hypogonadal men
    • Yin A, Alfadhli E, Htun M, et al. Dietary fat modulates the testosterone pharmacokinetics of a new self-emulsifying formulation of oral testosterone undecanoate in hypogonadal men. J Androl 2012; 33: 1282-90.
    • (2012) J Androl , vol.33 , pp. 1282-1290
    • Yin, A.1    Alfadhli, E.2    Htun, M.3
  • 44
    • 10444270959 scopus 로고    scopus 로고
    • Striant SR: A novel, effective and convenient testosterone therapy for male hypogonadism
    • Korbonits M, Kipnes M, Grossman AB. Striant SR: A novel, effective and convenient testosterone therapy for male hypogonadism. Int J Clin Pract 2004; 58: 1073-80.
    • (2004) Int J Clin Pract , vol.58 , pp. 1073-1080
    • Korbonits, M.1    Kipnes, M.2    Grossman, A.B.3
  • 45
    • 84863443850 scopus 로고    scopus 로고
    • The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men
    • Dinsmore WW, Wyllie MG. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men. Br J Urol Int 2012; 110: 162-9.
    • (2012) Br J Urol Int , vol.110 , pp. 162-169
    • Dinsmore, W.W.1    Wyllie, M.G.2
  • 46
    • 0032931818 scopus 로고    scopus 로고
    • Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years
    • Behre HM, von Eckardstein S, Kliesch S, et al. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clin Endocrinol 1999; 50: 629-35.
    • (1999) Clin Endocrinol , vol.50 , pp. 629-635
    • Behre, H.M.1    Von Eckardstein, S.2    Kliesch, S.3
  • 47
    • 67349236649 scopus 로고    scopus 로고
    • Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions
    • Raynaud JP, Augés M, Liorzou L, et al. Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions. Int J Pharm 2009; 375: 28-32.
    • (2009) Int J Pharm , vol.375 , pp. 28-32
    • Raynaud, J.P.1    Augés, M.2    Liorzou, L.3
  • 48
    • 2442543161 scopus 로고    scopus 로고
    • Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
    • Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metabolism 2004; 89: 2085-98.
    • (2004) J Clin Endocrinol Metabolism , vol.89 , pp. 2085-2098
    • Wang, C.1    Cunningham, G.2    Dobs, A.3
  • 50
    • 84869792056 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up
    • Behre HM, Tammela TL, Arver S, et al. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male 2012; 15: 198-207.
    • (2012) Aging Male , vol.15 , pp. 198-207
    • Behre, H.M.1    Tammela, T.L.2    Arver, S.3
  • 51
    • 23844454948 scopus 로고    scopus 로고
    • Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: A multicentre trial
    • Kühnert B, Byrne M, Simoni M, et al., for the Wolff Multi-Centre Study Group. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: A multicentre trial. Eur J Endocrinol 2005; 153: 317-26.
    • (2005) Eur J Endocrinol , vol.153 , pp. 317-326
    • Kühnert, B.1    Byrne, M.2    Simoni, M.3
  • 52
    • 58449105426 scopus 로고    scopus 로고
    • Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies
    • de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies. Hum Reprod 2009; 24: 425-8.
    • (2009) Hum Reprod , vol.24 , pp. 425-428
    • De Ronde, W.1
  • 53
    • 85030400613 scopus 로고    scopus 로고
    • Virilization in two pre-pubertal children exposed to topical androgen
    • Nelson D, Ho J, Pacaud D, et al. Virilization in two pre-pubertal children exposed to topical androgen. J Pediatr Endocrinol Metabolism 2013; 24: 1-5.
    • (2013) J Pediatr Endocrinol Metabolism , vol.24 , pp. 1-5
    • Nelson, D.1    Ho, J.2    Pacaud, D.3
  • 54
    • 26644446120 scopus 로고    scopus 로고
    • Effects of testosterone on sexual function in men: Results of a meta-analysis
    • Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: Results of a meta-analysis. Clin Endocrinol 2005; 63: 381-94.
    • (2005) Clin Endocrinol , vol.63 , pp. 381-394
    • Isidori, A.M.1    Giannetta, E.2    Gianfrilli, D.3
  • 55
    • 80054827093 scopus 로고    scopus 로고
    • Onset of effects of testosterone treatment and time span until maximum effects are achieved
    • Saad F, Aversa A, Isidori AM, et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011; 165: 675-85.
    • (2011) Eur J Endocrinol , vol.165 , pp. 675-685
    • Saad, F.1    Aversa, A.2    Isidori, A.M.3
  • 56
    • 0642343055 scopus 로고    scopus 로고
    • A simple self-report diary for assessing psychosexual function in hypogonadal men
    • Lee KK, Berman N, Alexander GM, et al. A simple self-report diary for assessing psychosexual function in hypogonadal men. J Androl 2003; 24: 688-98.
    • (2003) J Androl , vol.24 , pp. 688-698
    • Lee, K.K.1    Berman, N.2    Alexander, G.M.3
  • 57
    • 78651276680 scopus 로고    scopus 로고
    • The NERI Hypogonadism Screener: Psychometric validation in male patients and controls
    • Rosen RC, Araujo AB, Connor, et al. The NERI Hypogonadism Screener: Psychometric validation in male patients and controls. Clin Endocrinol 2011; 74: 248-56.
    • (2011) Clin Endocrinol , vol.74 , pp. 248-256
    • Rosen, R.C.1    Araujo, A.B.2    Connor3
  • 58
    • 78650788563 scopus 로고    scopus 로고
    • Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)
    • Buvat J, Montorsi F, Maggi M, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) . J Sex Med 2011; 8: 284-93.
    • (2011) J Sex Med , vol.8 , pp. 284-293
    • Buvat, J.1    Montorsi, F.2    Maggi, M.3
  • 59
    • 84927940597 scopus 로고    scopus 로고
    • Testosterone and erection
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. 4th ed. Cambridge: Cambridge University Press
    • Maggi M, Behre HG. Testosterone and erection. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 251-67.
    • (2012) Testosterone: Action, Deficiency, Substitution , pp. 251-267
    • Maggi, M.1    Behre, H.G.2
  • 60
    • 84902112192 scopus 로고    scopus 로고
    • Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone
    • Yassin DJ, Yassin AA, Hammerer PG. Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone. J Sex Med 2014; 11: 543-52.
    • (2014) J Sex Med , vol.11 , pp. 543-552
    • Yassin, D.J.1    Yassin, A.A.2    Hammerer, P.G.3
  • 61
    • 84877607887 scopus 로고    scopus 로고
    • Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk
    • Nehra A, Jackson G, Miner M, et al. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol 2013; 189: 2031-8.
    • (2013) J Urol , vol.189 , pp. 2031-2038
    • Nehra, A.1    Jackson, G.2    Miner, M.3
  • 62
    • 0033304542 scopus 로고    scopus 로고
    • Effect of testosterone treatment on bone mineral density in men over 65 years of age
    • Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metabolism 1999; 84: 1966-72.
    • (1999) J Clin Endocrinol Metabolism , vol.84 , pp. 1966-1972
    • Snyder, P.J.1    Peachey, H.2    Hannoush, P.3
  • 63
    • 84879535214 scopus 로고    scopus 로고
    • Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome
    • Rodriguez-Tolrá J, Torremadé J, di Gregorio S, et al. Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome. Andrology 2013; 1: 570-5.
    • (2013) Andrology , vol.1 , pp. 570-575
    • Rodriguez-Tolrá, J.1    Torremadé, J.2    Di Gregorio, S.3
  • 64
    • 69949092976 scopus 로고    scopus 로고
    • Osteoporotic Fractures in Men Study Group. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men
    • LeBlanc ES, Nielson CM, Marshall LM, et al., Osteoporotic Fractures in Men Study Group. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metabolism 2009; 94: 3337-46.
    • (2009) J Clin Endocrinol Metabolism , vol.94 , pp. 3337-3346
    • LeBlanc, E.S.1    Nielson, C.M.2    Marshall, L.M.3
  • 65
    • 66149152173 scopus 로고    scopus 로고
    • The role of estrogens for male bone health
    • Ohlsson C, Vandenput L. The role of estrogens for male bone health. Eur J Endocrinol 2009; 160: 883-9.
    • (2009) Eur J Endocrinol , vol.160 , pp. 883-889
    • Ohlsson, C.1    Vandenput, L.2
  • 66
    • 0035724191 scopus 로고    scopus 로고
    • The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males
    • Zitzmann M, Brune M, Kornmann B, et al. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol 2001; 55: 649-57.
    • (2001) Clin Endocrinol , vol.55 , pp. 649-657
    • Zitzmann, M.1    Brune, M.2    Kornmann, B.3
  • 67
    • 84900552741 scopus 로고    scopus 로고
    • Effects of testosterone replacement therapy on bone metabolism in male postsurgical hypogonadotropic hypogonadism: Focus on the role of androgen receptor CAG polymorphism
    • Jan 24 [Epub ahead of print]
    • Tirabassi G, Delli Muti N, Gioia A, et al. Effects of testosterone replacement therapy on bone metabolism in male postsurgical hypogonadotropic hypogonadism: Focus on the role of androgen receptor CAG polymorphism. J Endocrinol Investig 2014 Jan 24 [Epub ahead of print].
    • (2014) J Endocrinol Investig
    • Tirabassi, G.1    Delli Muti, N.2    Gioia, A.3
  • 68
    • 84897766291 scopus 로고    scopus 로고
    • Progressive improvement of T-scores in men with osteoporosis and subnormal serum testosterone levels upon treatment with testosterone over six years
    • Haider A, Meergans U, Traish A, et al. Progressive improvement of T-scores in men with osteoporosis and subnormal serum testosterone levels upon treatment with testosterone over six years. Int J Endocrinol 2014. http://dx.doi.org/10. 1155/2014/496948. ID 496948.
    • (2014) Int J Endocrinol
    • Haider, A.1    Meergans, U.2    Traish, A.3
  • 69
    • 79955472500 scopus 로고    scopus 로고
    • Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone
    • Bojesen A, Birkebæk N, Kristensen K, et al. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int 2011; 22: 1441-50.
    • (2011) Osteoporos Int , vol.22 , pp. 1441-1450
    • Bojesen, A.1    Birkebæk, N.2    Kristensen, K.3
  • 70
    • 77953955158 scopus 로고    scopus 로고
    • Novel genetic aspects of Klinefelter's syndrome
    • Tüttelmann F, Gromoll J. Novel genetic aspects of Klinefelter's syndrome. Mol Hum Reprod 2010; 16: 386-95.
    • (2010) Mol Hum Reprod , vol.16 , pp. 386-395
    • Tüttelmann, F.1    Gromoll, J.2
  • 71
    • 84861973260 scopus 로고    scopus 로고
    • Osteoporosis in men: An Endocrine Society Clinical Practice Guideline
    • Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabolism 2012; 97: 1802-22.
    • (2012) J Clin Endocrinol Metabolism , vol.97 , pp. 1802-1822
    • Watts, N.B.1    Adler, R.A.2    Bilezikian, J.P.3
  • 72
    • 79955536360 scopus 로고    scopus 로고
    • Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism
    • Sonmez A, Haymana C, Bolu E, et al. Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism. Eur J Endocrinol 2011; 164: 759-64.
    • (2011) Eur J Endocrinol , vol.164 , pp. 759-764
    • Sonmez, A.1    Haymana, C.2    Bolu, E.3
  • 73
    • 84906329056 scopus 로고    scopus 로고
    • Klinefelter Syndrome: The commonest form of hypogonadism, but often overlooked or untreated
    • Nieschlag E. Klinefelter Syndrome: The commonest form of hypogonadism, but often overlooked or untreated. Dtsch Arzteblatt Int 2013; 110: 347-53.
    • (2013) Dtsch Arzteblatt Int , vol.110 , pp. 347-353
    • Nieschlag, E.1
  • 74
    • 84885371224 scopus 로고    scopus 로고
    • Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss
    • Epub ahead of print]
    • Saad F, Haider A, Doros G, et al. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obes (Silver Springs) 2013; 20. http://dx.doi.org/10.1002/oby.20407 [Epub ahead of print].
    • (2013) Obes (Silver Springs , pp. 20
    • Saad, F.1    Haider, A.2    Doros, G.3
  • 75
    • 84896689377 scopus 로고    scopus 로고
    • Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study
    • Traish AM, Haider A, Doros G, et al. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study. Int J Clin Pract 2014; 68: 314-29.
    • (2014) Int J Clin Pract , vol.68 , pp. 314-329
    • Traish, A.M.1    Haider, A.2    Doros, G.3
  • 76
    • 70349105993 scopus 로고    scopus 로고
    • Prediction of metabolic syndrome by low serum testosterone levels in men: Results from the study of health in Pomerania
    • Haring R, Völzke H, Felix SB, et al. Prediction of metabolic syndrome by low serum testosterone levels in men: Results from the study of health in Pomerania. Diabetes 2009; 58: 2027-31.
    • (2009) Diabetes , vol.58 , pp. 2027-2031
    • Haring, R.1    Völzke, H.2    Felix, S.B.3
  • 77
    • 69949178483 scopus 로고    scopus 로고
    • Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone
    • Heufelder AE, Saad F, Bunck MC, et al. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 2009; 30: 726-33.
    • (2009) J Androl , vol.30 , pp. 726-733
    • Heufelder, A.E.1    Saad, F.2    Bunck, M.C.3
  • 78
    • 84888251991 scopus 로고    scopus 로고
    • Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes
    • Muraleedharan V, Marsh H, Kapoor D, et al. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol 2013; 169: 725-33.
    • (2013) Eur J Endocrinol , vol.169 , pp. 725-733
    • Muraleedharan, V.1    Marsh, H.2    Kapoor, D.3
  • 79
    • 84878704250 scopus 로고    scopus 로고
    • Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. Placebo in a population of men with type 2 diabetes
    • Hackett G, Cole N, Bhartia M, et al. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med 2013; 10: 1612-27.
    • (2013) J Sex Med , vol.10 , pp. 1612-1627
    • Hackett, G.1    Cole, N.2    Bhartia, M.3
  • 80
    • 84873809952 scopus 로고    scopus 로고
    • Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: A prospective cohort study
    • Epub ahead of print]
    • Banks E, Joshy G, Abhayaratna WP, et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: A prospective cohort study. PLOS Med 2013. http://dx.doi.org/10.1371/journal. pmed.1001372 [Epub ahead of print].
    • (2013) PLOS Med
    • Banks, E.1    Joshy, G.2    Abhayaratna, W.P.3
  • 81
    • 84927926514 scopus 로고    scopus 로고
    • Testosterone and cardiovascular disease
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. 4th ed. Cambridge: Cambridge University Press
    • Channer KS, Jones TH. Testosterone and cardiovascular disease. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 207-34.
    • (2012) Testosterone: Action, Deficiency, Substitution , pp. 207-234
    • Channer, K.S.1    Jones, T.H.2
  • 82
    • 84896766780 scopus 로고    scopus 로고
    • Sequelae of doping with anabolic steroids
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. 4th ed. Cambridge: Cambridge University Press
    • Vorona E, Nieschlag E. Sequelae of doping with anabolic steroids. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 535-46.
    • (2012) Testosterone: Action, Deficiency, Substitution , pp. 535-546
    • Vorona, E.1    Nieschlag, E.2
  • 83
    • 84879486573 scopus 로고    scopus 로고
    • Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism
    • Liao CH, Wu YN, Lin FY, et al. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Andrology 2013; 1: 563-9.
    • (2013) Andrology , vol.1 , pp. 563-569
    • Liao, C.H.1    Wu, Y.N.2    Lin, F.Y.3
  • 84
    • 84864297656 scopus 로고    scopus 로고
    • Testosterone supplementation in heart failure: A meta-analysis
    • Toma M, McAlister FA, Coglianese EE, et al. Testosterone supplementation in heart failure: A meta-analysis. Circ Heart Fail 2012; 5: 315-21.
    • (2012) Circ Heart Fail , vol.5 , pp. 315-321
    • Toma, M.1    McAlister, F.A.2    Coglianese, E.E.3
  • 85
    • 77954421915 scopus 로고    scopus 로고
    • Adverse events associated with testosterone administration
    • Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109-22.
    • (2010) N Engl J Med , vol.363 , pp. 109-122
    • Basaria, S.1    Coviello, A.D.2    Travison, T.G.3
  • 86
    • 84876176964 scopus 로고    scopus 로고
    • Testosterone therapy and cardiovascular events among men: A systematic review and meta-analysis of placebo-controlled randomized trials
    • Xu L, Freeman G, Cowling BJ, et al. Testosterone therapy and cardiovascular events among men: A systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 2013; 11: 108.
    • (2013) BMC Med , vol.11 , pp. 108
    • Xu, L.1    Freeman, G.2    Cowling, B.J.3
  • 87
    • 84887056433 scopus 로고    scopus 로고
    • Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels
    • Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. J Am Med Assoc 2013; 310: 1829-36.
    • (2013) J Am Med Assoc , vol.310 , pp. 1829-1836
    • Vigen, R.1    O'Donnell, C.I.2    Barón, A.E.3
  • 88
    • 84899654297 scopus 로고    scopus 로고
    • Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men
    • Jan
    • Finkle WD, Greenland S, Ridgeway GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014 Jan; 9: E85805.
    • (2014) PLoS One , vol.9 , pp. e85805
    • Finkle, W.D.1    Greenland, S.2    Ridgeway, G.K.3
  • 89
    • 84861969972 scopus 로고    scopus 로고
    • Testosterone treatment and mortality in men with low testosterone levels
    • Shores MM, Smith NL, Forsberg CW, et al. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metabolism 2012; 97: 2050-8.
    • (2012) J Clin Endocrinol Metabolism , vol.97 , pp. 2050-2058
    • Shores, M.M.1    Smith, N.L.2    Forsberg, C.W.3
  • 90
    • 33749550602 scopus 로고    scopus 로고
    • Persistent intraprostatic androgen concentrations after medical castration in healthy men
    • Page ST, Lin DW, Mostaghel EA, et al. Persistent intraprostatic androgen concentrations after medical castration in healthy men. J Clin Endocrinol Metabolism 2006; 91: 3850-6.
    • (2006) J Clin Endocrinol Metabolism , vol.91 , pp. 3850-3856
    • Page, S.T.1    Lin, D.W.2    Mostaghel, E.A.3
  • 91
    • 84864808462 scopus 로고    scopus 로고
    • Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: A randomized, controlled trial
    • Mostaghel EA, Lin DW, Amory JK, et al. Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: A randomized, controlled trial. J Clin Endocrinol Metabolism 2012; 97: 2809-17.
    • (2012) J Clin Endocrinol Metabolism , vol.97 , pp. 2809-2817
    • Mostaghel, E.A.1    Lin, D.W.2    Amory, J.K.3
  • 92
    • 84879474222 scopus 로고    scopus 로고
    • Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: Implementation of standardized management guidelines
    • Cheung AS, Pattison D, Bretherton I, et al. Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: Implementation of standardized management guidelines. Andrology 2013; 1: 583-9.
    • (2013) Andrology , vol.1 , pp. 583-589
    • Cheung, A.S.1    Pattison, D.2    Bretherton, I.3
  • 93
    • 84880036090 scopus 로고    scopus 로고
    • Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy
    • Pastuszak AW, Pearlman AM, Lai WS, et al. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol 2013; 190: 639-44.
    • (2013) J Urol , vol.190 , pp. 639-644
    • Pastuszak, A.W.1    Pearlman, A.M.2    Lai, W.S.3
  • 94
    • 0023922039 scopus 로고
    • Follow-up of 30 Klinefelter males treated with testosterone
    • Nielsen J, Pelsen B, Sørensen K. Follow-up of 30 Klinefelter males treated with testosterone. Clin Genet 1988; 33: 262-9.
    • (1988) Clin Genet , vol.33 , pp. 262-269
    • Nielsen, J.1    Pelsen, B.2    Sørensen, K.3
  • 95
    • 84890790057 scopus 로고    scopus 로고
    • A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with Klinefelter syndrome or anorchia
    • Rogol AD, Swerdloff RS, Reiter EO, et al. A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with Klinefelter syndrome or anorchia. J Adolesc Health 2014; 54: 20-5.
    • (2014) J Adolesc Health , vol.54 , pp. 20-25
    • Rogol, A.D.1    Swerdloff, R.S.2    Reiter, E.O.3
  • 96
    • 84874205380 scopus 로고    scopus 로고
    • Positive effects of short course androgen therapy on the neurodevelopmental outcome in boys with 47,XXY syndrome at 36 and 72 months of age
    • Samango-Sprouse CA, Sadeghin T, Mitchell FL, et al. Positive effects of short course androgen therapy on the neurodevelopmental outcome in boys with 47,XXY syndrome at 36 and 72 months of age. Am J Med Genet A 2013; 161A: 501-8.
    • (2013) Am J Med Genet A , vol.161 A , pp. 501-508
    • Samango-Sprouse, C.A.1    Sadeghin, T.2    Mitchell, F.L.3
  • 98
    • 84884906598 scopus 로고    scopus 로고
    • Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor
    • Mehta A, Bolyakov A, Roosma J, et al. Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor. Fertil Steril 2013; 100: 970-4.
    • (2013) Fertil Steril , vol.100 , pp. 970-974
    • Mehta, A.1    Bolyakov, A.2    Roosma, J.3
  • 99
    • 84855871070 scopus 로고    scopus 로고
    • Can pubertal boys with Klinefelter syndrome benefit from spermatogonial stem cell banking?
    • Van Saen D, Gies I, De Schepper J, et al. Can pubertal boys with Klinefelter syndrome benefit from spermatogonial stem cell banking? Hum Reprod 2012; 27: 323-30.
    • (2012) Hum Reprod , vol.27 , pp. 323-330
    • Van Saen, D.1    Gies, I.2    De Schepper, J.3
  • 100
    • 0031691345 scopus 로고    scopus 로고
    • Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: A review of 42 cases
    • Büchter D, Behre HM, Kliesch S, et al. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: A review of 42 cases. Eur J Endocrinol 1998; 139: 298-303.
    • (1998) Eur J Endocrinol , vol.139 , pp. 298-303
    • Büchter, D.1    Behre, H.M.2    Kliesch, S.3
  • 101
    • 29144469309 scopus 로고    scopus 로고
    • Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled studies
    • Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled studies. J Gerontol Ser A Biol Sci Med Sci 2005; 60: 1451-7.
    • (2005) J Gerontol Ser A Biol Sci Med Sci , vol.60 , pp. 1451-1457
    • Calof, O.M.1    Singh, A.B.2    Lee, M.L.3
  • 102
    • 83055173275 scopus 로고    scopus 로고
    • Testicular dysfunction in systemic diseases
    • In: Nieschlag E, Behre HM, Nieschlag S, editors. 3rd ed. Heidelberg: Springer
    • Sartorius GA, Handelsman DJ. Testicular dysfunction in systemic diseases. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: Male reproductive health and dysfunction. 3rd ed. Heidelberg: Springer; 2010. p. 339-64.
    • (2010) Andrology: Male Reproductive Health and Dysfunction , pp. 339-364
    • Sartorius, G.A.1    Handelsman, D.J.2
  • 103
    • 79961243360 scopus 로고    scopus 로고
    • Low testosterone in men with type 2 diabetes: Significance and treatment
    • Grossmann M. Low testosterone in men with type 2 diabetes: Significance and treatment. J Clin Endocrinol Metabolism 2011; 96: 2341-53.
    • (2011) J Clin Endocrinol Metabolism , vol.96 , pp. 2341-2353
    • Grossmann, M.1
  • 104
    • 84875863886 scopus 로고    scopus 로고
    • Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: Longitudinal results from the European Male Ageing Study
    • Camacho EM, Huhtaniemi IT, O'Neill, et al., EMAS Group. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: Longitudinal results from the European Male Ageing Study. Eur J Endocrinol 2013; 168: 445-55.
    • (2013) Eur J Endocrinol , vol.168 , pp. 445-455
    • Camacho, E.M.1    Huhtaniemi, I.T.2    O'Neill3
  • 105
    • 60349088152 scopus 로고    scopus 로고
    • Healthier lifestyle predicts higher circulating testosterone in older men: The health in men study
    • Yeap BB, Almeida OP, Hyde Z, et al. Healthier lifestyle predicts higher circulating testosterone in older men: The health in men study. Clin Endocrinol 2009; 70: 455-63.
    • (2009) Clin Endocrinol , vol.70 , pp. 455-463
    • Yeap, B.B.1    Almeida, O.P.2    Hyde, Z.3
  • 106
    • 84881522951 scopus 로고    scopus 로고
    • Longitudinal changes in testosterone over five years in community-dwelling men
    • Shi Z, Araujo AB, Martin S, et al. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metabolism 2013; 98: 3289-97.
    • (2013) J Clin Endocrinol Metabolism , vol.98 , pp. 3289-3297
    • Shi, Z.1    Araujo, A.B.2    Martin, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.